Clonal evolution patterns in acute myeloid leukemia with NPM1 mutation
NPM1 gene mutation is a founding event in acute myeloid leukaemia. Here, the authors find that at relapse, some patients lose the NPM1 mutation and show distinct mutational and gene expression patterns, highlighting a potential route for relapse.
Guardado en:
Autores principales: | Sibylle Cocciardi, Anna Dolnik, Silke Kapp-Schwoerer, Frank G. Rücker, Susanne Lux, Tamara J. Blätte, Sabrina Skambraks, Jan Krönke, Florian H. Heidel, Tina M. Schnöder, Andrea Corbacioglu, Verena I. Gaidzik, Peter Paschka, Veronica Teleanu, Gudrun Göhring, Felicitas Thol, Michael Heuser, Arnold Ganser, Daniela Weber, Eric Sträng, Hans A. Kestler, Hartmut Döhner, Lars Bullinger, Konstanze Döhner |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ab42b55dd8f048919990526549391171 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Microscale and Mesoscale Aeolian Processes of Sandy Coastal Foredunes from Background to Extreme Conditions
por: Bianca R. Charbonneau, et al.
Publicado: (2021) -
Biological Effects of BET Inhibition by OTX015 (MK-8628) and JQ1 in NPM1-Mutated (NPM1c) Acute Myeloid Leukemia (AML)
por: Hanane Djamai, et al.
Publicado: (2021) -
Biological and therapeutic implications of a unique subtype of NPM1 mutated AML
por: Arvind Singh Mer, et al.
Publicado: (2021) -
Nucleolar protein NPM1 is essential for circovirus replication by binding to viral capsid
por: Jianwei Zhou, et al.
Publicado: (2020) -
NPM1 is a Novel Therapeutic Target and Prognostic Biomarker for Ewing Sarcoma
por: Yangfan Zhou, et al.
Publicado: (2021)